Login Create Account
 
Power Your Document

Pharmaceutical Licensing


# 56526
Pharmaceutical Licensing
An analysis of compulsory licensing of pharmaceutical products.
4,300 words (approx. 17.2 pages) | 12 sources | MLA | 2004 United States


Paper Summary:

This paper highlights the causes and effects of the compulsory licensing of pharmaceutical products. The paper discusses the fundamental positions, attitude, inclination, and concerns of the developed world and the under-developed world with regard to the intellectual property rights of the pharmaceutical products. The paper also concentrates on the subject of the intellectual property rights of the biotechnology products. The paper also exposes the priorities of both the developed world and the under-developed world, priorities that have been a major hurdle in all previous negotiations on Intellectual Property Rights (IPR) protection. Subsequently, the paper gives practical recommendations that ought to be followed in all future negotiations so that both parties can derive maximum benefits from the patentability of pharmaceutical products.

From the Paper:

"Over the years, it has become a general belief that biodiversity will pave the way for a solution to almost all the diseases that exist today and continue to negatively influence our lives. This belief has led scientists to take further steps in the Research and development (R&D) of biotechnology. These steps comprise of various compounds, compounds that are biologically active, compounds that are natural resources, for example microbes, insects, fungi, marine organisms, and plants. However, laboratories are not capable of producing these complex biologically active and complex compounds. This is because the key places of genetic biodiversity are situated in the tropical and the subtropical regions of the world (Tara, 1994). Therefore, it is imperative for biotech scientists to go into the tropical forests with the purpose of locating these biologically active compounds."

Cite this paper

APA Citation:

Pharmaceutical Licensing (2012, January 15). Retrieved February 12, 2012, from http://www.academon.com/Research-Paper-Pharmaceutical-Licensing/56526

MLA Citation:

"Pharmaceutical Licensing" 15 January 2012. Web. 12 Feb. 2012. <http://www.academon.com/Research-Paper-Pharmaceutical-Licensing/56526>




ATTENTION:

Your browser does not have cookies enabled.

Our shopping cart will not function properly.
Downloadable version: $ 68.95
ADD TO CART »
You will be able to download, read and edit this file once you buy this document
Shopping Cart
Currency:
AcaDemon.com is that one place
Published by:

Calwriter US
Publisher Since:
Nov 28, 2004
We've been publishing our papers on AcaDemon for several years now and have a very high satisfaction rate with our customers. Our writers invest a great deal of time and effort in researching and writing all of their papers and their professionalism as writers is reflected in those papers.
Seller Assistance
Share Our Success